NextCure, Inc. (NXTC) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$55.84M | -0.3% |
| 2024 | -$55.65M | +11.3% |
| 2023 | -$62.72M | +16.1% |
| 2022 | -$74.73M | -7.7% |
| 2021 | -$69.39M | -89.6% |
| 2020 | -$36.60M | -8.5% |
| 2019 | -$33.74M | -48.0% |
| 2018 | -$22.80M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$55.84M | -0.3% |
| 2024 | -$55.65M | +11.3% |
| 2023 | -$62.72M | +16.1% |
| 2022 | -$74.73M | -7.7% |
| 2021 | -$69.39M | -89.6% |
| 2020 | -$36.60M | -8.5% |
| 2019 | -$33.74M | -48.0% |
| 2018 | -$22.80M | — |